FY19
Assets82.86
Net Worth14.37
Total Debt27.82
RevenueAnnualised basis106.28
EBITDAAnnualised basis4.67
PATAnnualised basis0.63
EBITDA Margin (%)4.39
Open 31st Jan 2020 · Close 6th Feb 2020 · Listing 14th Feb 2020
The shares listed at ₹51.70, a 1.37% move from the issue price. Chandra Bhagat Pharma is a SME IPO with an issue size of ₹10.20 crore, proposed for listing on BSE SME. The offer opens on 31st Jan 2020 and closes on 6th Feb 2020. The issue structure includes a fresh issue of ₹9.69 crore. The current listing schedule points to 14th Feb 2020.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 2000 | — |
| Object | Amount |
|---|---|
| To Meet Incremental Working Capital Requirements | ₹7.00 Cr |
| Setting up Distribution and Warehousing Centre’s | ₹1.50 Cr |
| General Corporate Purpose | ₹0.95 Cr |
| To meet Public Issue Expenses | ₹0.75 Cr |
| KPI | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Lead Manger Fees including Underwriting Commission | 0.18 |
| 2 | Fees Payable to Registrar to the Issue | 0.01 |
| 3 | Fees Payable for Marketing and Advertisement Expenses | 0.38 |
| 4 | Fees Payable to Regulators including Stock Exchanges | 0.03 |
| 5 | Payment for Printing and Distribution of Issue Stationaries | 0.01 |
| 6 | Others (Fees Payable to Peer Review Auditor, Fees to Legal Advisors, Marketing Expenses, Custodians Fees, Market Making, Brokerage, Processing Fees for Application and Miscellaneous Expenses) | 0.14 |
| 7 | Processing Fees to SCSBs for ASBA Application Procured by the Members of the Syndicate or Registered Brokers and Submitted with SCSB’s | 0 |
| 8 | Processing Fees Issued to Issuer Bank for UPI Mechanism w.r.t. Application forms procured by the members of the Syndicate, Registered Brokers, RTAs or the CDP’s and submitted to them | 0 |
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Chandra Bhagat Pharma Ltd IPO | — | 51.00 x | — | — |
| Bio Medica IPO | — | 13.45 x | — | — |
| Goldline Pharmaceutical IPO | — | 14.56 x | — | — |
| Speciality Medicines IPO | — | 10.49 x | — | — |
| Expense | Amount |
|---|---|
| To Meet Incremental Working Capital Requirements | ₹7.00 Cr |
| Setting up Distribution and Warehousing Centre’s | ₹1.50 Cr |
| General Corporate Purpose | ₹0.95 Cr |
| To meet Public Issue Expenses | ₹0.75 Cr |
Register for subscription, GMP, allotment and listing notifications.
Share your name and 10-digit mobile number. Our team will call you within 24 hours for personalized IPO guidance.